05/14/2024
3:20 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Oncology Institute, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
3:03 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Oncology Institute, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
3:55 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Oncology Institute, Inc. (Filer)
| Form DEF 14A | |
05/02/2024
3:57 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Oncology Institute, Inc. (Filer)
| Form DEFA14A | |
04/26/2024
2:11 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Oncology Institute, Inc. (Filer)
| Form ARS | |
04/22/2024
3:30 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Oncology Institute, Inc. (Filer)
| Form 10-K/A | |
04/22/2024
3:31 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Oncology Institute, Inc. (Filer)
| Form PRE 14A | |
|
03/28/2024
5:47 AM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Oncology Institute, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/30/2024
6:07 PM | Havencrest Healthcare Partners GP, LLC (Reporting)
Havencrest Healthcare Partners, L.P. (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
TOI HC I, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/26/2024
6:19 PM | Havencrest Healthcare Partners GP, LLC (Reporting)
Havencrest Healthcare Partners, L.P. (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
TOI HC I, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
7:02 PM | Havencrest Healthcare Partners GP, LLC (Reporting)
Havencrest Healthcare Partners, L.P. (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
TOI HC I, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:00 PM | Havencrest Healthcare Partners GP, LLC (Reporting)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute (Subject)
Oncology Institute, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
4:01 PM | Havencrest Healthcare Partners GP, LLC (Reporting)
Havencrest Healthcare Partners, L.P. (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
TOI HC I, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
4:06 PM | Havencrest Healthcare Partners, L.P. (Filed by)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute (Subject)
Oncology Institute, Inc. (Subject)
| Form SC 13D/A | |
12/28/2023
4:58 PM | BARASCH RICHARD A (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:46 PM | Hively Brad (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:38 PM | Johnson Karen Marie (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:27 PM | Kaushal Mohit (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:58 PM | O'Meara Maeve (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:06 PM | McGeorge Anne (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:16 PM | Ling Gabriel (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:09 PM | Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
Pacala Mark L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
2:26 PM | Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
Shah Mihir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
6:42 PM | Castle Jeremy (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
8:01 PM | Hively Brad (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
7:47 PM | Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
Virnich Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
7:37 PM | Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
Podnos Yale (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
6:27 PM | Hively Brad (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
4:27 PM | Hively Brad (Reporting)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute (Subject)
Oncology Institute, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
3:40 PM | Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
Podnos Yale (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
5:49 PM | Hively Brad (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
4:17 PM | Hively Brad (Reporting)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute (Subject)
Oncology Institute, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023
7:00 AM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Oncology Institute, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
1:36 PM | Castle Jeremy (Reporting)
Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/30/2023
2:04 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Oncology Institute, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
9:20 AM | FMR LLC (Filed by)
Oncology Institute, Inc. (Subject)
Oncology Institute, Inc. (Subject)
Oncology Institute (Subject)
Oncology Institute, Inc. (Subject)
| Form SC 13G/A | |
06/15/2023
5:41 AM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Oncology Institute, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
4:28 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Oncology Institute, Inc. (Filer)
| Form DEFA14A | |
06/14/2023
4:22 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Oncology Institute, Inc. (Filer)
| Form 8-K/A | |
06/12/2023
7:09 AM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Oncology Institute, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2023
7:43 PM | Oncology Institute, Inc. (Issuer)
Oncology Institute, Inc. (Issuer)
Oncology Institute (Issuer)
Oncology Institute, Inc. (Issuer)
Shah Mihir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Warren Buffett's "mystery stock" (Ad) WARNING: Read This Before the Next Fed Meeting
Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some |
05/22/2023
4:09 PM | Oncology Institute, Inc. (Filer)
Oncology Institute, Inc. (Filer)
Oncology Institute (Filer)
Oncology Institute, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
